Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00427193 · ClinicalTrials.gov registry record · NA

CALERIE: Comprehensive Assessment of Long-Term Effects of Reducing Intake of Energy

A NA study of Aging, sponsored by Duke University.

Completed
Registry status
NA
Development phase
238
Enrollment target
3
Study locations

NCT00427193 is a NA study of Aging that has completed, run by Duke University. The registered enrollment target is 238 participants, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (89% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00427193, a NA study of Aging, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
238 participants
Enrollment target
3
Study locations

Study Summary

The purpose of this study is to test the hypothesis that two years of sustained 25% caloric restriction (CR) in men age 21-50 (inclusive) and women age 21-47 (inclusive) will slow aging and protect against age-related disease processes.

Conditions Studied

Interventions

  • BEHAVIORAL Control
  • BEHAVIORAL Caloric Restriction (CR)

Study Locations (3)

Louisiana

  • Pennington Biomedical Research Center - Baton Rouge

Massachusetts

  • Jean Mayer Human Nutrition Research Center on Aging at Tufts University - Boston

Missouri

  • Washington University School of Medicine - St Louis

Trial Details

FieldValue
Enrollment Target 238 participants
Start Date 2007-05
Est. Completion 2012-11
Phase NA

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT00427193

The ClinicalTrials.gov registry entry for NCT00427193 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 238 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (89% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Aging appearing as the primary indexed condition, and to 2 interventions - of which Control is the first listed.

NCT00427193 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Louisiana, Massachusetts, Missouri.

Frequently Asked Questions

What is clinical trial NCT00427193 about?

NCT00427193 is a clinical study titled "CALERIE: Comprehensive Assessment of Long-Term Effects of Reducing Intake of Energy". The purpose of this study is to test the hypothesis that two years of sustained 25% caloric restriction (CR) in men age 21-50 (inclusive) and women age 21-47 (inclusive) will slow aging and protect against age-related disease processes.

What is the current status of trial NCT00427193?

This trial is currently completed. It is a NA study. The enrollment target is 238 participants. The study started on 2007-05. Estimated completion is 2012-11.

What conditions does trial NCT00427193 study?

This clinical trial studies the following conditions: Aging.

What interventions are being tested in trial NCT00427193?

The interventions under investigation include: Control (BEHAVIORAL), Caloric Restriction (CR) (BEHAVIORAL).

Who is sponsoring clinical trial NCT00427193?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00427193 being conducted?

This trial has 3 study locations across Louisiana, Massachusetts, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aging

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.